Senseonics to Participate in the Jefferies Healthcare Conference
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Day: May 26, 2022
AllStar Health Brands Inc. Announces the Formation of AllStar Global Media
MIAMI, FL / ACCESSWIRE / May 26, 2022 / AllStar Health Brands Inc (OTC PINK:ALST) ("AllStar" or "the Company") announces...
Allstarhealth Brands And Advent Galaxy Agree To Halt The Joint Venture
MIAMI, FL / ACCESSWIRE / May 26, 2022 / AllStar Health Brands Inc OTC PINK:ALST) ("AllStar" or "the Company") announces...
West Island Releases Q1 Financial Results
Toronto, Ontario--(Newsfile Corp. - May 26, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) ("West...
Universal Health Corporation Launches Preceptorship Program with Radford University School of Nursing
Universal Health Corporation partners with Radford University to provide clinical hours.ROANOKE, VA / ACCESSWIRE / May 26, 2022 / Universal...
Support for Caregivers Means Better Care for Loved Ones with COPD
MISSION, KS / ACCESSWIRE / May 26, 2022 / (Family Features) Chances are you know someone who takes care of...
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences
MINNEAPOLIS, MN / ACCESSWIRE / May 26, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic...
StageZero Life Sciences Announces Resignation of CFO
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / May 26, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) ("StageZero" or...
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / May 26, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF), (OTCQB:RLFTF, RLFTY) ("Relief"), a biopharmaceutical company...
Goodbody Health Announces the Launch of Its Core Health Diagnostic Check
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is...
Empower Clinics Granted Accreditation For Mobile Covid-19 Testing Solutions Throughout British Columbia
New Certification Makes Empower's Testing Solutions Even More Convenient for its CustomersVANCOUVER, BC / ACCESSWIRE / May 26, 2022 /...
Europe’s Leading Psychedelic Conference Returns to Amsterdam
The OPEN Foundation invites you to the Interdisciplinary Conference on Psychedelic Research this September, featuring the world’s best experts on...
Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting
Meeting to highlight updated data from the Phase 1/2a study of CLN-081 CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) --...
Galecto to Present New Data on Oral Galectin-3 Inhibitor GB1211 at the 2022 ASCO Annual Meeting
Novel galectin-3-based mechanism of PD-1/PD-L1 checkpoint inhibitor resistance identified Galecto’s oral galectin-3 inhibitor candidate, GB1211, reverses galectin-3 induced blockade of...
Rakovina Therapeutics Inc. Announces Q1 2022 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company committed...
WIMI Hologram Academy: Research and Application of Aircraft Component Assembly Technology Based on Virtual Reality
HONG KONG, May 26, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in Germany and Israel TEL AVIV,...
SELLAS Reports Preliminary Data Showing Clinical Benefit from Phase 1/2 Clinical Trial of Galinpepimut-S (GPS) in Combination with Keytruda® in Patients with WT1+ Advanced Ovarian Cancer
- Overall Response Rate of 7.7 percent is similar to checkpoint inhibitors alone - - Disease Control Rate for GPS...
Nanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood Samples
EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the...
CBD of Denver Signs Licensing Agreement with UK Luxury CBD Brand OTO
Denver, Colorado--(Newsfile Corp. - May 26, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and...